Granules India Reports Unaudited Standalone and Consolidated Financial Results for Q2 2026

Granules India Limited has announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2025. The company reported a standalone total income of ₹8,994.98 million for the quarter and a consolidated total income of ₹12,958.39 million. The Board of Directors approved these results at a meeting held on November 13, 2025.

Standalone Financial Performance

For the quarter ended September 30, 2025, Granules India reported a standalone total income of ₹8,994.98 million, compared to ₹5,707.71 million for the quarter ended September 30, 2024. Profit for the period stood at ₹1,206.13 million, while total comprehensive income reached ₹1,114.03 million.

For the half-year ended September 30, 2025, the company’s standalone total income was ₹17,228.58 million compared to ₹14,245.29 million for the half-year ended September 30, 2024. The profit for the half-year was ₹1,900.98 million, and total comprehensive income amounted to ₹1,800.58 million.

Consolidated Financial Performance

Granules India’s consolidated total income for the quarter ended September 30, 2025, was reported as ₹12,958.39 million, an increase from ₹9,698.74 million in the corresponding quarter of the previous year. The profit for the quarter stood at ₹1,306.06 million, and the total comprehensive income was ₹1,700.72 million.

For the half-year ended September 30, 2025, the consolidated total income was ₹25,222.90 million as compared to ₹21,518.03 million for the half-year ended September 30, 2024. The profit for the half-year was ₹2,432.42 million, and total comprehensive income amounted to ₹3,017.36 million.

Key Highlights and Developments

The Gagillapur facility, which received a USFDA warning letter in February 2025, has been undergoing remediation. The company voluntarily paused operations in September 2024 to address USFDA observations and has initiated a remediation plan with independent consultants. This impacted revenue due to slower production and increased expenses, primarily consultancy and air freight.

On April 10, 2025, Senn Chemicals AG was acquired, becoming a step-down subsidiary, and has been consolidated since that date.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!